XML 33 R21.htm IDEA: XBRL DOCUMENT v3.24.2
Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents The following table provides a reconciliation of cash and cash equivalents, and restricted cash and cash equivalents reported within the accompanying consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying consolidated statements of cash flows. The restricted cash and cash equivalents presented below are included in “Restricted investments” in the accompanying consolidated balance sheets.
June 30,
 20242023
(In millions)
Cash and cash equivalents$4,354 $4,910 
Restricted cash and cash equivalents64 47 
Total cash, cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows
$4,418 $4,957 
Schedule of Restricted Cash and Cash Equivalents The following table provides a reconciliation of cash and cash equivalents, and restricted cash and cash equivalents reported within the accompanying consolidated balance sheets that sum to the total of the same such amounts presented in the accompanying consolidated statements of cash flows. The restricted cash and cash equivalents presented below are included in “Restricted investments” in the accompanying consolidated balance sheets.
June 30,
 20242023
(In millions)
Cash and cash equivalents$4,354 $4,910 
Restricted cash and cash equivalents64 47 
Total cash, cash equivalents, and restricted cash and cash equivalents presented in the consolidated statements of cash flows
$4,418 $4,957 
Schedule of Receivables
June 30,
2024
December 31,
2023
(In millions)
Government receivables$2,185 $2,354 
Pharmacy rebate receivables339 330 
Other707 420 
Total receivables$3,231 $3,104